Nantahala Capital Management, LLC 13D and 13G filings for Crescent Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:46 pm Sale | 2022-12-31 | 13G | Crescent Biopharma, Inc. CBIO | Nantahala Capital Management, LLC | 292 1.400% | -6,710 (-95.83%) | Filing |
| 2022-02-14 08:05 am Purchase | 2021-12-31 | 13G | Crescent Biopharma, Inc. CBIO | Nantahala Capital Management, LLC | 7,002 8.800% | 2,272 (+48.05%) | Filing |
| 2021-02-12 3:18 pm Purchase | 2020-12-31 | 13G | Crescent Biopharma, Inc. CBIO | Nantahala Capital Management, LLC | 4,729 8.400% | 2,012 (+74.05%) | Filing |